Transparency, accountability and independence
The International Gaucher Alliance is committed to transparency, accountability and maintaining its independence as a patient-led organisation.
We want our community, members, partners and supporters to understand how the IGA is funded and how our resources support our work for people affected by Gaucher disease around the world.
2025 income : £299,486

IGA receives funding from a range of sources to support its programmes, projects and activities. Corporate organisations can provide support through unrestricted grants or funding for specific projects.
2025 expenditure : £238,600

The 2025 Impact Report identifies project costs as including project management, administration and professional fees.
IGA uses its resources to deliver programmes, projects and activities that support the global Gaucher community, alongside the operational costs required to run the organisation responsibly.
IGA works constructively with organisations that support our work while maintaining its independence as a patient-led organisation.
IGA will only accept unrestricted grants up to an amount not exceeding 35% of its annual budget from any one pharmaceutical company.This principle is stated in the IGA's existing funding information and recent Impact Reports.
IGA's website is operated independently, and its funders have no editorial control over its contents.
See where our support comes from
We publish information about our funding so that our community can understand where financial support for the IGA comes from.
Responsible financial planning
IGA maintains financial reserves as part of responsible financial planning. This helps protect the continuity of our work and our ability to serve the global Gaucher community.The IGA's previous Impact Reports describe its reserves policy in these terms.
Our policies help guide how the IGA accepts financial support and works with commercial organisations.
Our approach to accepting donations and financial support.
Our Code of Practice sets out principles for the IGA's relationships with pharmaceutical companies, including written agreements and transparency around financial and non-financial support.
For those who want to look at the underlying financial information, the IGA publishes its financial and impact reporting documents.
A detailed overview of the IGA's work and financial highlights for 2025.
Registered Charity Number: 1192011
Company Limited by Guarantee Registered in England & Wales No. 06653373
This website is supported by our funders. The International Gaucher Alliance maintains full editorial independence, and our funders have no influence over the content published on this website.
© 2026 International Gaucher Alliance. All rights reserved.